Willeke van de Kasteele

Design and use of conditional MHC class I ligands

Mireille Toebes, Miriam Coccoris, Adriaan D. Bins et al. · Nature Medicine · 2006 · 352 citations

Life Sciences, Immunology, Molecular Biology +12

Adhesion of T and B lymphocytes to extracellular matrix and endothelial cells can be regulated through the beta subunit of VLA

E. van de Wiel-van Kemenade, Yvette van Kooyk, AJ de Boer et al. · The Journal of Cell Biology · 1992 · 134 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Selecting highly affine and well-expressed TCRs for gene therapy of melanoma

Annelies Jorritsma, Raquel Gomez-Eerland, Maarten Dokter et al. · Blood · 2007 · 102 citations · Full text

Medicine, Molecular Biology, Oncology +14

RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells

Lisa Borkner, Andrew Kaiser, Willeke van de Kasteele et al. · Cancer Immunology Immunotherapy · 2010 · 55 citations · Full text

Life Sciences, Immunology, Oncology +16

Immune-Escape Markers in Relation to Clinical Outcome of Advanced Melanoma Patients Following Immunotherapy

Esther P.M. Tjin, Gabrielle Krebbers, Kimberley J. Meijlink et al. · Cancer Immunology Research · 2014 · 34 citations

Life Sciences, Immunology, Oncology +17